Skip to content

Application of High-flow nasal cannula oxygen therapy in examination and treatment of heart disease patients under general anesthesia

High-flow nasal cannula oxygen therapy and hypoxia during transesophageal echocardiography:a clinical, randomized, controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068412
Enrollment
Unknown
Registered
2023-02-17
Start date
2023-02-20
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transesophageal echocardiography

Interventions

nasal cannula group:nasal cannula oxygen
HFNC supportive oxygen therapy group:HFNC oxygen

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients undergoing transesophageal echocardiography under anesthesia between the ages of 18–75 years,with the American Society of Anesthesiologists (ASA) physical status classifications I–III.

Exclusion criteria

Exclusion criteria: Severe heart failure and obvious arrhythmias; severe hypertension and hypotension; unstable angina pectoris and myocardial infarction; presence of coagulation dysfunction or congenital or acquired upper digestive tract disease; severe liver or kidney disease. Patients with difficulty in endotracheal intubation (such as Markov grade III or above, limited mouth opening, nail-chin distance 40]; patients who are allergic to propofol, eggs, soybeans or egg whites; other researchers do not consider it appropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
SPO2;

Secondary

MeasureTime frame
Duration of diagnosis and treatment;Comfort Score;propofol dosage;adverse events during the peri-examination;Satisfaction score;PaCO2, SpO2, HR, MAP after patients entered the room and the end of the TEE;use of vasoactive drugs;General information and airway assessment;

Countries

China

Contacts

Public ContactShi Hongwei

Nanjing First Hospital

mdshw@163.com+86 139 5209 5550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026